Viewing Study NCT00738257


Ignite Creation Date: 2025-12-24 @ 7:07 PM
Ignite Modification Date: 2025-12-28 @ 12:13 PM
Study NCT ID: NCT00738257
Status: COMPLETED
Last Update Posted: 2010-05-17
First Post: 2008-08-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Prospective, Multicentre, Open-label Randomised Controlled Study to Investigate the Effectiveness of Pamidronate in the Prevention of Bone Loss in de Novo Renal Transplant Patients.
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module